SO-010 - Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors.
Saved in:
| Title: | SO-010 - Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. |
|---|---|
| Authors: | Garralda, E.1 (AUTHOR), Fiedler, W.2 (AUTHOR), Matos, I.3 (AUTHOR), Rolling, C.4 (AUTHOR), Kebenko, M.4 (AUTHOR), Klinghammer, K.4 (AUTHOR), Conte, G.4 (AUTHOR), Raspagliesi, F.4 (AUTHOR), Habel, B.4 (AUTHOR), Baumeister, H.4 (AUTHOR), Ochsenreither, S.4 (AUTHOR), Zurlo, A.4 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement, Vol. 30, piv125-iv125. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
